Efficacy of non-ablative fractional 1440-nm laser therapy for treatment of facial acne scars in patients with rosacea: a prospective,interventional study

Lasers in Medical Science - Acne scarring is one of the most common facial skin disorders. The appropriate treatments for acne scars in patients with rosacea have not been studied. This study was...     

Comparative study of different transplantation methods of adipose tissue-derived stem cells in the treatment of erectile dysfunction caused by cavernous nerve injury

We aimed to compare intracavernosal injection (ICI), tail vein injection (IV), and periprostatic injection (PPI) of adipose-derived stem cells (ADSCs) for their ability to improve erectile function in cavernous nerve injury-induced erectile dysfunction (CNIED) rats and to explore the possible mechanism. Eighty-four male SD rats were divided into the sham group (n = 6), BCNI group (bilateral CN crush injury, n = 6), PBS-ICI group (n = 6), PBS-IV group (n = 6), PBS-PPI group (n = 6), ADSC-ICI group (n = 18), ADSC-IV group (n = 18) and ADSC-PPI group (n = 18). ADSCs were labelled with 5-ethynyl-2′-deoxyuridine (EdU), and six rats each in the ADSC-ICI group, ADSC-IV group, and ADSC-PPI group were sacrificed 2, 7, and 28 days after injection. EdU-labelled ADSCs were tracked by immunofluorescence staining. The intracavernosal pressure (ICP)/mean arterial pressure (MAP) ratio, neuronal nitric oxide synthase (nNOS)-positive nerve fibres in the dorsal penile nerve and the smooth muscle/collagen ratio in the cavernosum between groups were also evaluated. ADSCs can significantly improve erectile function through ICI or IV. The two are similar in efficacy and superior to PPI. The mechanism may be that after CN injury, ADSCs are recruited to around the MPG and secrete a variety of neurotrophic factors that promote the repair of the CN, thereby improving erectile function.     

Overlapping obesity-related glomerulopathy and immunoglobulin A nephropathy: clinical and pathologic characteristics and prognosis

Clinical and Experimental Nephrology - In this study, we investigated the clinical and pathologic characteristics and prognosis of overlapping obesity-related glomerulopathy (ORG) and...     

前列腺癌与增生性病变的流式细胞分析

应用流式细胞分析术（ＦＣＭ）对２０例前列腺癌（ＰＣ）和１５例良性前列腺组织作了ＤＮＡ含量检测，着重分析了ＰＣ及增生性病变的细胞增殖指数（ＰＩ）与ＤＮＡ指数（ＤＩ）。结果表明在良恶性前列腺组织中有明显差异（Ｐ＜０．０１）。２０例ＰＣ的组织学分级与ＦＣＭ检测结果有关，ＰＣ－Ⅲ与ＰＣ１－Ⅰ、ＰＣ－Ⅱ与ＰＣ－Ⅰ、ＰＣ－Ⅲ与ＢＰＨ的ＰＩ、ＤＩ相差显著（Ｐ＜０．０１）。本研究结果提示良恶性前列腺病变的ＰＩ与ＤＩ能较客观地反应不同细胞的生物活性，并对分化低、分级高的ＰＣ的恶性程度判断及其预后的推测，以及癌前病变的分析有意义。     

Lymphokine-activated killer (LAK) cells modulate the effects of IL-2 on a T cell-mediated immune response.

The ability of LAK cells and/or IL-2 to affect the course of an established T cell response was examined in a delayed-type hypersensitivity (DTH) model. IL-2 greatly increased the magnitude of the response at 24 h, while LAK cells alone had no effect. The administration of LAK cells and IL-2 together also had no effect on the magnitude of the DTH response, demonstrating that LAK cells were able to remove the enhancement seen with IL-2 alone. The presence of LAK cells reduced the serum half-life of IL-2 significantly, but not to an extent able to account for the observed loss of IL-2 induced DTH enhancement. IL-2 administration influenced cell phenotypes in the spleen and draining lymph nodes (DLN), as well as increasing splenic weight; the additional presence of LAK cells markedly altered these effects of IL-2 in the spleen (but not the DLN). Taken together, these results suggest that LAK cells interact with activated T-cells within the immune system and modulate their function.     

大肠癌“移行粘膜”病理变化研究——粘液组化、免疫组化及电镜观察

对200例大肠癌旁“移行粘膜”进行了粘液组化HID／AB及PAT／KOH／PAS检测,单克隆抗体MC3和CEA免疫组化标记,凝集素PNA、UEA－1及DBA受体测定,扫描电镜观察。其结果与10例正常直肠粘膜、130例癌组织、155例各型腺瘤型息肉及3－5个月胎儿大肠粘膜进行对照。结果表明大肠粘膜从良性到恶性的各阶段粘液组化及免疫组化的改变有显著差异（P＜0．05或P＜0．01）,癌旁“移行粘膜”也存在类似癌及胎儿大肠的不成熟性病理变化,异常范围88．0％的病例在2－3cm以内。